Findings come as ACC/AHA guidelines recognize polygenic risk as an ASCVD risk enhancer MENLO PARK, Calif., March 20, 2026 /PRNewswire/ -- MyOme, a leader in clinical whole-genome analysis and ...

Core-focused exercises for lower abs including crunches, planks, and twists.

Current schizophrenia medications treat symptoms such as hallucinations and delusions, but do little for cognitive symptoms ...

For women age 70 and over with a common form of breast cancer, determining "the right size" of treatment can be challenging, ...

Around 70,000 people die each year from infections with the hepatitis E virus. There is currently neither a vaccine nor a specific drug against this ...

Positive interim Phase 1/2 INSPIRE DUCHENNE data reported at the 2026 MDA Annual Meeting continued to suggest differentiated clinical, safety and tolerability profiles; SGT-003 ...

First and only FDA-approved therapy for the treatment of acquired hypothalamic obesity, a rare disease characterized by accelerated and sustained weight gain caused by hypothalamic injury or dysfuncti ...

PANTHERx® Rare Pharmacy, the trusted leader and innovator in patient access and support services for personalized rare disease care, announced that it was selected by Rhythm Pharmaceuticals, ...

Thoracic aortic dissection is often approached as an acute and localised event, and pathological examination has traditionally focused on the dissected segment. In daily practice, however, most ...

Long-term lithium therapy remains the most effective maintenance treatment for bipolar disorder, yet it poses a significant risk of progressive renal impairment in a subset of patients. Early ...